Brief: Glenmark Life Sciences Q1 Profit 1.11 Billion Rupees
July 25 (Reuters) - Glenmark Life Sciences Ltd
GLEM.NS :
* Q1 PROFIT 1.11 BILLION RUPEES
* Q1 REVENUE FROM OPERATIONS 5.89 BILLION RUPEES
Further company coverage: GLEM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alivus Life Sciences
See all newsBrief: Alivus Life Sciences Incorporates Subsidiary Alivus Life Sciences Do Brasil Ltda In Brazil
Brief: Alivus Life Sciences To Buy 76% Stake In Iqgen-X Pharma For Approx 91.2 Million Rupees
India's Alivus rises to 15-month high as brokerages optimistic about drugmaker's annual outlook
India's Alivus Life Sciences rises after quarterly profit increase
Brief: Alivus Life Sciences Ltd March-Quarter Profit 1.63 Billion Rupees